Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23529)

• Formulation Name: Raltegravir Potassium eq 25mg base Chewable tablet
• Company: Merck Sharp Dohme

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Raltegravir	(DMYURI6)	Human immunodeficiency virus infection	1C62	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonium hydroxide	(E00687)	Not Available	Alkalizing agent
Crospovidone	(E00626)	Not Available	Disintegrant
Ethyl cellulose	(E00699)	Not Available	Coating agent; Microencapsulating agent; Binding agent; Diluent; Viscosity-controlling agent
Fructose	(E00447)	2723872	Flavoring agent
Haematite red	(E00236)	14833	Colorant
Hydroxypropyl cellulose	(E00632)	Not Available	Binding agent; Coating agent; Emulsifying agent; Film/Membrane-forming agent; Modified-release agent; Suspending agent; Viscosity-controlling agent
Hypromellose	(E00634)	Not Available	Coating agent
Magnesium stearate	(E00208)	11177	lubricant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Medium-chain triglyceride	(E00640)	Not Available	Emollient; Lubricant; Surfactant
Monoammonium glycyrrhizate	(E00352)	62074	Emulsifying agent; Flavoring agent
Oleic acid	(E00421)	445639	Emulsifying agent; Penetration agent; Solubilizing agent
Polyethylene glycol 400	(E00653)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Saccharin sodium anhydrous	(E00443)	656582	Flavoring agent
Sodium citrate dihydrate	(E00369)	71474	Alkalizing agent; Buffering agent; Complexing agent; Emulsifying agent
Sodium stearyl fumarate	(E00545)	23665634	lubricant
Sorbitan tristearate	(E00516)	17800859	Dispersing agent; Emulsifying agent; Solubilizing agent; Surfactant; Suspending agent; Vaccine adjuvant
Sucralose	(E00370)	71485	Flavoring agent